Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is a haematological malignancy for which reliable prognostic markers are needed in view of its clinical heterogeneity. In approximately 50% of CLL patients, immunoglobulin (Ig) rearrangements are modified by somatic hypermutation (SHM), a process that represents a reliable prognostic indicator of favourable progression. In this study, we investigated SHM in 37 Brazilian CLL patients and identified the preferential involvement of specific immunoglobulin gene families and segments through PCR-amplified fragments or subcloned fragments. Forty-one rearrangements were observed and 37 of them were functional. A 98% homology cut-off with germinal sequences showed 18 patients (48.7%) with SHM. Unmutated cases showed a poorer clinical outcome. V H3 was the most frequent V H family, followed by V H4. The V H4-39 segment was the most frequently used, mainly in unmutated cases, while the V H3 family was predominant in mutated cases. The D3 and J H4/J H6 families were the most frequently observed.
Main Authors: | Pimentel,Beatriz Jatobá, Stefanoff,Cláudio Gustavo, Moreira,Aline Santos, Seuánez,Héctor N., Zalcberg,Ilana Renault |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Genética
2008
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572008000400007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations
by: Zalcberg,Ilana, et al.
Published: (2020) -
Thyroid nodule: first manifestation of chronic lymphocytic leukaemia
by: Gonçalves,Ana, et al.
Published: (2015) -
Chronic Lymphocytic Leukemia (CLL): evaluation of AKT protein kinase and microRNA gene expression related to disease pathogenesis
by: Gomes,Lorena Caixeta, et al.
Published: (2022) -
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
by: Moreno-Martínez,Estela, et al.
Published: (2022) -
Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens
by: Delgado, Julio, et al.
Published: (2017-04)